The Readout Loud
STAT
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Episodes
Mentioned books
Jun 27, 2019 • 26min
Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing
Can Botox make Big Pharma attractive? What qualifies as a "cabal"? And will the CRISPR patent fight outlive us all?
Jun 20, 2019 • 27min
Episode 68: A controversial desire drug, courtroom genealogy, & the quest for longer life
Is desire a matter of medicine? Can you convict on genealogy? And what do you get the alleged bride who has it all?
Jun 13, 2019 • 25min
Episode 67: Biohacking meets bureaucracy, and the latest twist in CRISPR world
Is biohacking a crime? Who came up with the latest CRISPR trick? And did Rage Against the Machine sell out?
Jun 6, 2019 • 27min
Episode 66: The future of cancer treatment, blockbusters interrupted, & an infamous biotech party
Who won ASCO? Is pharma sandbagging its blockbusters? And what do gladiators have to do with biotech?
Jun 4, 2019 • 29min
Episode 65: A special episode from the halls of the ASCO meeting
What can be done to improve HPV vaccination rates in the U.S.? How does the genetic signature of a tumor lead to an effective cancer drug? What’s it like being a doctor and a cancer patient?
May 30, 2019 • 24min
Episode 64: Feuding professors, failing businesses, and journalism 101
Who's guilty of "clickbait"? Are spit tubes a bad business? And why are academics emulating Pusha T?
May 23, 2019 • 32min
Episode 63: Your ASCO preview, genetic whiplash, and a journalist's experience with cancer
What should you watch for at the year's biggest cancer conference? Why are people having 23andMe-induced identity crises? And what's it like to be at once a journalist and a cancer patient?
May 16, 2019 • 23min
Episode 62: Drug pricing partisanship, tech's march into health care, and Tinder for clinical trials
Has drug price reform already stalled? How far has tech come in medicine? And should there be an app for that?
May 9, 2019 • 25min
Episode 61: Pharma felonies, cardiac CRISPR, and a strange day at the FDA
Are law-breaking pharma executives the new mob bosses? Can genome editing preventing heart attacks? And can the FDA regulate drug prices?
May 2, 2019 • 22min
Episode 60: Boardroom drama, whiskey-fueled science, & millionaires on mushrooms
Is Biogen bracing for a fight? What does Jack Daniels have to do with immunotherapy? And will "micro-dosing" light the way to actual therapies?
